Abstract Library

#4497 Complex management of a long-term gastrinoma survivor with multimodal treatment approaches

Introduction: The prognosis of pancreatic gastrinomas is influenced by tumour burden, extent of metastasis, and treatment response, with 5-year survival rates ranging from 20% to 40%. Treatment for well-differentiated tumours typically include locoregional therapies, long-acting somatostatin analogues, molecular targeted agents, radionuclides, and chemotherapy.

Conference:

Presenting Author: Puscasu A

Authors: Puscasu A, Miron M, Croitoru A,

Keywords: gastrinoma, neuroendocrine tumour, long survival, complex management,

#4463 Evaluating multi-visceral resection for locally advanced and metastatic pancreatic neuroendocrine tumours (PNETs): Feasibility, safety and complications

Introduction: Pancreatic neuroendocrine tumours (PNETs) are rare but clinically significant neoplasms. Surgery can play a significant role in the multimodal treatment of PNETs. Multi-visceral resection involving organs in the left upper quadrant (LUQ) can be used with curative or cytoreductive intent in selected cases.

Conference:

Presenting Author:

Authors: Ee J, Patel R, Hamady Z, Pike T, Karavias D,

Keywords: neuroendocrine, tumour, pancreatic, multivisceral,

#4040 Surgery of small bowel neuroendocrine tumors: 10 years’ experience at a tertiary centre

Introduction: Small bowel neuroendocrine tumors are often found when they have already spread. These tumors are hard to treat, and there are many different treatments.

Conference:

Presenting Author:

Authors: Chibane A, Bouzid C, Boudiaf Z, Kheloufi M, Cherchar K,

Keywords: neuroendocrine, small intestine, surgery, multimodal treatment,

#3683 Distinct clinico-pathological features of neuroendocrine liver metastases originating from the pancreas and rectum

Introduction: The treatment response and prognosis still remain poor in the metastatic neuroendocrine neoplasms.

Conference:

Presenting Author: Takahiro T

Authors: Tsuchikawa T, Aya M, Tanaka K, Nakanishi Y, Asano T,

Keywords: Neuroendocrine liver metastasis, pancreas, rectum, clinical characteristics,

#2879 Lung Neuroendocrine Tumors: Experience of Medical Oncology Department of Hospital 1st November 1954 Oran

Introduction: Lung neuroendocrine tumors account for 25% of all neuroendocrine tumors. It is a heterogeneous group that meets morphological criteria; immunohistochemical and molecular; defining 4 groups: Typical and atypical carcinoid tumors, neuroendocrine carcinomas with large cell and small cells. Carcinoid syndrome is rare in these tumors and the treatment is based on surgery for localized forms and multimodal treatment for metastatic forms.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Kehili H, Bengueddach A, Kaid M, Allaoui M, Benabdellah H,

Keywords: lung neuroendocrine tumors, rare, prognosis,